Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
- Conditions
- Avoidant/Restrictive Food Intake DisorderDyspepsiaCognitive Behavioral TherapyBehavioral MedicineFeeding and Eating DisordersFunctional DyspepsiaAppetite RegulationPost-prandial Distress Syndrome
- Interventions
- Behavioral: Cognitive Behavioral Therapy
- Registration Number
- NCT05587127
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.
- Detailed Description
The purpose of this study is to conduct a randomized controlled trial (RCT) of a cognitive-behavioral treatment (CBT) compared to usual care as the control with adults with functional dyspepsia who also meet criteria for avoidant/restrictive food intake disorder (ARFID). Participants randomized into the CBT group will receive eight 1-hour sessions delivered weekly via the MGH-approved secure video platform Enterprise Zoom while the usual care group will be allowed to continue with treatment they are already receiving at the time of randomization. Participants in the usual care group will be offered CBT after study participation. We will determine the feasibility and acceptability of the CBT and explore changes in clinical outcomes and preliminary mechanisms.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cognitive Behavioral Therapy Cognitive Behavioral Therapy Subjects will receive cognitive behavioral therapy for functional dyspepsia with avoidant restrictive food intake disorder.
- Primary Outcome Measures
Name Time Method Retention Throughout study completion, an average of 3 years At the end of the study, we will calculate the percentage of participants who complete at least 6 of the 8 CBT sessions.
Interventionist Fidelity ratings Throughout study completion, an average of 3 years At the end of the study, we will calculate fidelity, which measures the percentage of sessions that 100% of the CBT content was delivered.
Enrollment Throughout study completion, an average of 3 years At the end of the study, we will calculate the percentage of participants who consent to initiate the study from the total who are offered.
Assessment completion Throughout study completion, an average of 3 years At the end of the study, we will calculate the percentage of participants who complete all assessments in each CBT and usual care groups.
Client Satisfaction Week 12 The Client Satisfaction Questionnaire (CSQ) is an 8 item self-report measure that assesses treatment satisfaction. Higher scores indicate greater treatment satisfaction.
- Secondary Outcome Measures
Name Time Method Short Form Nepean Dyspepsia Inventory (SF-NDI) Weeks 0, 6, and 12 The Short Form Nepean Dyspepsia Inventory (SF-NDI) includes a 15 item symptoms checklist to assess functional dyspepsia symptom severity. It also includes 10 items scored on a 5-point Likert scale measuring functional dyspepsia-related quality of life; subscales include interference with daily activities, knowledge/control, tension, work/study, and eating/drinking.
Trial Locations
- Locations (1)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States